A. Narayana

766 total citations
46 papers, 526 citations indexed

About

A. Narayana is a scholar working on Infectious Diseases, Genetics and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, A. Narayana has authored 46 papers receiving a total of 526 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Infectious Diseases, 13 papers in Genetics and 12 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in A. Narayana's work include Glioma Diagnosis and Treatment (13 papers), Tuberculosis Research and Epidemiology (9 papers) and Brain Metastases and Treatment (6 papers). A. Narayana is often cited by papers focused on Glioma Diagnosis and Treatment (13 papers), Tuberculosis Research and Epidemiology (9 papers) and Brain Metastases and Treatment (6 papers). A. Narayana collaborates with scholars based in United States and India. A. Narayana's co-authors include G.R.K. Sarma, S. Kailasam, Chandra Immanuel, Prem Venkatesan, Srikanth Tripathy, Shahzad Raza, P. R. Somasundaram, Philip H. Gutin, S. Devadatta and J.B. Selkon and has published in prestigious journals such as Journal of Clinical Oncology, Antimicrobial Agents and Chemotherapy and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

A. Narayana

42 papers receiving 487 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Narayana United States 13 175 157 145 102 98 46 526
Keith Nieforth United States 16 214 1.2× 249 1.6× 42 0.3× 35 0.3× 88 0.9× 31 792
Hélène Sauvageon France 10 179 1.0× 122 0.8× 184 1.3× 14 0.1× 127 1.3× 19 534
Lawrence Galitz United States 8 87 0.5× 149 0.9× 86 0.6× 28 0.3× 114 1.2× 12 480
R Streuli Switzerland 12 41 0.2× 58 0.4× 58 0.4× 13 0.1× 32 0.3× 40 412
Young Sok Lee South Korea 15 34 0.2× 496 3.2× 21 0.1× 48 0.5× 92 0.9× 35 773
Gina Eagle United States 13 189 1.1× 243 1.5× 31 0.2× 15 0.1× 28 0.3× 39 598
Craig W. Freyer United States 12 76 0.4× 83 0.5× 53 0.4× 11 0.1× 199 2.0× 47 524
Fengjuan Xuan United States 13 148 0.8× 212 1.4× 75 0.5× 29 0.3× 94 1.0× 25 1.1k
Janel Long-Boyle United States 15 32 0.2× 31 0.2× 83 0.6× 72 0.7× 101 1.0× 43 578
Mohammad Wehbi United States 9 31 0.2× 218 1.4× 13 0.1× 46 0.5× 149 1.5× 26 712

Countries citing papers authored by A. Narayana

Since Specialization
Citations

This map shows the geographic impact of A. Narayana's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Narayana with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Narayana more than expected).

Fields of papers citing papers by A. Narayana

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Narayana. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Narayana. The network helps show where A. Narayana may publish in the future.

Co-authorship network of co-authors of A. Narayana

This figure shows the co-authorship network connecting the top 25 collaborators of A. Narayana. A scholar is included among the top collaborators of A. Narayana based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Narayana. A. Narayana is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Immanuel, Chandra, et al.. (2015). Rifampin-lnduced Release of Hydrazine from Isoniazid. American Review of Respiratory Disease. 2 indexed citations
2.
Pawar, Rahul V., et al.. (2011). Multicentric Castleman’s Disease of the Central Nervous System. Clinical Neuroradiology. 22(3). 245–251. 1 indexed citations
3.
Narayana, A., Saroj Kunnakkat, Sharon L. Gardner, et al.. (2010). Bevacizumab in recurrent high-grade pediatric gliomas. Neuro-Oncology. 12(9). 985–990. 65 indexed citations
4.
Kumar, Vinodh A., F. Jung, James S. Babb, et al.. (2008). Comparison of dynamic susceptibility contrast MRI with conventional MRI in evaluating tumor response following bevacizumab therapy in recurrent high-grade gliomas. Journal of Clinical Oncology. 26(15_suppl). 2085–2085. 3 indexed citations
5.
Narayana, A., John G. Golfinos, Shahzad Raza, et al.. (2008). Change in Pattern of Relapse Following Anti-angiogenic Therapy in High Grade Glioma. International Journal of Radiation Oncology*Biology*Physics. 72(1). S11–S11. 1 indexed citations
6.
Narayana, A., Jenghwa Chang, Sunitha B. Thakur, et al.. (2007). Use of MR spectroscopy and functional imaging in the treatment planning of gliomas. British Journal of Radiology. 80(953). 347–354. 50 indexed citations
7.
Chan, Kelvin, W O'Meara, J. Zhung, et al.. (2006). 2391. International Journal of Radiation Oncology*Biology*Physics. 66(3). S427–S427. 1 indexed citations
8.
Lee, N., Ka Wah Chan, Justin E. Bekelman, et al.. (2006). 2372. International Journal of Radiation Oncology*Biology*Physics. 66(3). S416–S417. 1 indexed citations
9.
Mechalakos, James, Margie Hunt, N. Lee, et al.. (2005). Measurement of IMRT Head and Neck Setup Error Using an On-board Kilovoltage Imager. International Journal of Radiation Oncology*Biology*Physics. 63. S353–S354. 4 indexed citations
10.
Narayana, A., Jenghwa Chang, Sunitha B. Thakur, et al.. (2004). Use of MR spectroscopy and functional imaging in the treatment planning of gliomas. International Journal of Radiation Oncology*Biology*Physics. 60(1). S222–S223. 3 indexed citations
11.
Hunt, Margie, Andrew Jackson, A. Narayana, & N. Lee. (2004). The relationship between parotid gland-PTV overlap and the ability to achieve dosimetric sparing of the parotid using intensity modulated radiation therapy. International Journal of Radiation Oncology*Biology*Physics. 60(1). S178–S179. 1 indexed citations
12.
Narayana, A., Jason C. Chang, Sunitha B. Thakur, et al.. (2004). Use of MR spectroscopy and functional imaging in the treatment planning of gliomas. International Journal of Radiation Oncology*Biology*Physics. 60. S222–S223.
13.
Reddy, Sarada P., et al.. (2001). Stomal Recurrence in Patients With T1 Glottic Cancer After Salvage Laryngectomy for Radiotherapy Failures. American Journal of Clinical Oncology. 24(2). 124–127. 14 indexed citations
14.
Gurumurthy, Prema, et al.. (1990). Salivary levels of isoniazid and rifampicin in tuberculous patients. Tubercle. 71(1). 29–33. 20 indexed citations
15.
Sarma, G.R.K., et al.. (1990). Classification of children as slow or rapid acetylators based on concentrations of isoniazid in saliva following oral administration of body-weight and surface-area-related dosages of the drug.. PubMed. 27(2). 134–42. 9 indexed citations
16.
Gurumurthy, Prema, et al.. (1984). Assay Of Ethambutol In Pharmaceutical Preparations. Lung India. 2(1). 143. 3 indexed citations
17.
Selkon, J.B., S. Devadatta, D.A. Mitchison, et al.. (1964). THE EMERGENCE OF ISONIAZID-RESISTANT CULTURES IN PATIENTS WITH PULMONARY TUBERCULOSIS DURING TREATMENT WITH ISONIAZID ALONE OR ISONIAZID PLUS PAS.. PubMed. 31. 273–94. 44 indexed citations
18.
Ramakrishnan, C. V., Ankit Bhatia, S. Devadatta, et al.. (1962). The course of pulmonary tuberculosis in patients excreting organisms which have acquired resistance. Response to continued treatment for a second year with isoniazid alone or with isoniazid plus PAS.. PubMed. 26. 1–18. 7 indexed citations
19.
20.
Velu, S., Rebecca Andrews, J H Angel, et al.. (1961). Progress in the second year of patients with quiescent pulmonary tuberculosis after a year of domiciliary chemotherapy, and influence of further chemotherapy on the relapse rate.. PubMed. 25. 409–29. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Keith Nieforth Breakdown of academic impact, for papers by Hélène Sauvageon Breakdown of academic impact, for papers by Lawrence Galitz Breakdown of academic impact, for papers by R Streuli Breakdown of academic impact, for papers by Young Sok Lee Breakdown of academic impact, for papers by Gina Eagle Breakdown of academic impact, for papers by Craig W. Freyer Breakdown of academic impact, for papers by Fengjuan Xuan Breakdown of academic impact, for papers by Janel Long-Boyle Breakdown of academic impact, for papers by Mohammad Wehbi
Rankless by CCL
2026